Pharma Journalist 9091 posts 0 comments

Insilico Medicine has entered into a strategic collaboration with Takeda Pharmaceutical Company to accelerate AI-driven drug discovery, leveraging its proprietary Pharma.AI platform to…
Read More...

Novartis has received European Commission approval for Itvisma® (onasemnogene abeparvovec), expanding access to gene replacement therapy for children, teenagers and adults living with…
Read More...

Sanofi has reported positive Phase 3 results for Nexviazyme, also known as avalglucosidase alfa, in infants with infantile-onset Pompe disease, a rare and life-threatening genetic…
Read More...

Vertex Pharmaceuticals has received expanded approval from the U.S. Food and Drug Administration for CASGEVY® (exagamglogene autotemcel), allowing the gene-editing therapy to be used in…
Read More...

Innovent Biologics and Eli Lilly and Company have entered into a new distribution and promotion agreement for Verzenios® (abemaciclib) in mainland China, expanding their commercial…
Read More...

Zymeworks Inc. has agreed to acquire Theravance Biopharma, Inc. in an all-cash transaction valued at approximately $929 million, marking a significant consolidation in the biotechnology…
Read More...

Eli Lilly and Company has moved a step closer to expanding the use of its blood cancer therapy Jaypirca (pirtobrutinib) in Europe after receiving a positive opinion from the European…
Read More...

Talawar Tx Inc., a biotechnology company developing next-generation bispecific antibody therapies for immunology and inflammatory diseases, has signed a definitive business combination…
Read More...

AstraZeneca and YMCA of the USA (Y-USA) have launched a five-year, multimillion-dollar partnership aimed at improving cancer awareness, increasing screening and early detection rates,…
Read More...

Antares Therapeutics has entered into a strategic collaboration with Novartis to discover, develop, and commercialize a new generation of small-molecule cancer therapies targeting…
Read More...